Pusan, South Korea -- Intralesional interferon alfa-2b (Intron-A) can be a useful option for the treatment of rapidly growing keratoacanthomas, Chang-Keun Oh, M.D., Ph.D., said.
Highlights from AAD 2023
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
New Technology Could Allow Us to Rethink Alopecia Scores
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Pregnant Women with Skin Conditions May Require Dermatologic Intervention
Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies